Moneycontrol
Oct 13, 2016 01:17 PM IST | Source: PTI

Granules gets US FDA nod for anti-inflammatory drug

"US FDA has approved Abbreviated New Drug Application (ANDA) for Ibuprofen tablets USP, 200 mg (OTC) filed by Granules India Ltd," the company said in a BSE filing.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Pharma firm Granules today said it has received approval from the US health regulator for anti-inflammatory drug Ibuprofen tablets, in the US market.


"US FDA has approved Abbreviated New Drug Application (ANDA) for Ibuprofen tablets USP, 200 mg (OTC) filed by Granules India Ltd," the company said in a BSE filing.


The approved ANDA is the bio-equivalent to the reference listed drug product (RLD), Motrin IB Tablets, 200 mg, of Johnson & Johnson Consumer, Inc, it added.

Shares of Granules India Ltd were trading 0.62 percent higher at Rs 121 on BSE.

Sections
Follow us on
Available On